Track Cann Group Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Cann Group Limited CAN.AX Open Cann Group Limited in new tab

0.005000 AUD
P/E
0.50
EPS
0.01
P/B
0.23
ROE
72.56
Beta
0.15
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 28, 2026
P/E0.50
EPS0.01
Book Value0.02
Price to Book0.23
Debt/Equity43.64
% Insiders22.453%
Growth
Revenue Growth-0.30%
Estimates
Forward P/E0.02
Forward EPS0.30

DCF Valuation

Tweak assumptions to recompute fair value for Cann Group Limited (CAN.AX)
Currency: AUD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Cann Group Limited Logo Cann Group Limited Analysis (CAN.AX)

Australia Health Care Official Website Stock

Is Cann Group Limited a good investment? Cann Group Limited (CAN.AX) is currently trading at 0.005000 AUD.

In terms of valuation, the stock trades at a P/E ratio of 0.50. This relatively low multiple may signal that Cann Group Limited is undervalued compared to historical market norms.

Earnings Schedule: Cann Group Limited is expected to release its next earnings report on Aug. 28, 2026. The market consensus estimate for Forward EPS is 0.30.

Investor FAQ

Does Cann Group Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is Cann Group Limited?

Cann Group Limited is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Aug. 28, 2026. The company currently has a trailing EPS of 0.01.

Company Profile

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

Exchange Ticker
ASX (Australia) CAN.AX
PNK (United States) CNGGF

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion